Status:
COMPLETED
Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.
Lead Sponsor:
Pak Emirates Military Hospital
Conditions:
Dermatophyte Infection
Terbinafine Adverse Reaction
Eligibility:
All Genders
15-50 years
Phase:
PHASE3
Brief Summary
Study would be conducted to compare the efficacy and safety of double than usual dose oral terbinafine versus itraconazole in treatment of dermatophyte infections of skin in patient presenting at derm...
Detailed Description
* Study would be a randomized controlled trial, in which 120 subjects would be randomly divided into two equal groups of 60 each. * Each group would be prescribed double than usual dose of terbinafine...
Eligibility Criteria
Inclusion
- individuals with dermatophyte skin infection, aged 15-50 years with one or no co-morbidities.
Exclusion
- individuals with two or more co-morbidities or known cases of chronic liver disease.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04880980
Start Date
March 15 2021
End Date
March 15 2022
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pak Emirates Military Hospital
Rawalpindi, Punjab Province, Pakistan, 46000